Skip to main content
Erschienen in: Journal of Cancer Survivorship 5/2016

26.02.2016

Complementary and alternative medicine use among US cancer survivors

verfasst von: Gabriella M. John, Dawn L. Hershman, Laura Falci, Zaixing Shi, Wei-Yann Tsai, Heather Greenlee

Erschienen in: Journal of Cancer Survivorship | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

US cancer survivors commonly use vitamins/minerals and complementary and alternative medicine (CAM). We compare use of vitamins/minerals and CAM between adult cancer survivors and cancer-free adults and estimate annual out-of-pocket expenses.

Methods

Data on self-reported vitamin/mineral and CAM use in the past 12 months from the cross-sectional 2012 US National Health Interview Survey were used to estimate prevalence of use and out-of-pocket expenditures. The cohort included adults with (n = 2977) and without (n = 30,551) a self-reported cancer diagnosis.

Results

Approximately 79 % of cancer survivors and 68 % of cancer-free adults reported using ≥1 vitamins/minerals and/or CAM modality in the past year. Compared to cancer-free adults, cancer survivors were more likely to report use of vitamin/minerals (75 vs. 61 %, P < 0.001), non-vitamin/mineral natural products (24 vs. 19 %, P < 0.001), manipulative and body-based therapies (19 vs. 17 %, P = 0.03), and alternative medical systems (5 vs. 4 %, P = 0.04). Adult cancer survivors and cancer-free adults spent an annual estimated $6.7 billion and $52 billion out-of-pocket, respectively, on vitamins/minerals and CAM. Survivors spent 60 % of the total on vitamins/minerals ($4 billion), 18 % ($1.2 billion) on non-vitamin/mineral natural products, and 7 % ($0.5 billion) on massage.

Conclusions

Compared with cancer-free adults, a higher proportion of cancer survivors report vitamin/mineral and CAM use. Cancer survivors, who accounted for 6.9 % of the total population, accrued more than 11.4 % of the annual out-of-pocket costs on vitamins/minerals and CAM spent by US adults.

Implications for Cancer Survivors

Given the high use of vitamins/minerals and CAM in cancer survivors, studies are needed to analyze health outcomes and the cost/benefit ratio of such use.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report. 2009;(18):1–14 Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report. 2009;(18):1–14
2.
Zurück zum Zitat Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J. Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surv. 2011;5(1):8–17. doi:10.1007/s11764-010-0153-7.CrossRef Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J. Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surv. 2011;5(1):8–17. doi:10.​1007/​s11764-010-0153-7.CrossRef
5.
Zurück zum Zitat Mao JJ, Farrar JT, Xie SX, Bowman MA, Armstrong K. Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med. 2007;15(1):21–9. doi:10.1016/j.ctim.2006.07.006.CrossRefPubMed Mao JJ, Farrar JT, Xie SX, Bowman MA, Armstrong K. Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med. 2007;15(1):21–9. doi:10.​1016/​j.​ctim.​2006.​07.​006.CrossRefPubMed
6.
Zurück zum Zitat Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med. 2002;8(4):477–85. doi:10.1089/107555302760253676.CrossRefPubMed Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med. 2002;8(4):477–85. doi:10.​1089/​1075553027602536​76.CrossRefPubMed
10.
Zurück zum Zitat Willson S, Stussman B, Maitland A, Nahin RL. Role of self-concept in answering survey questions on complementary and alternative medicine: challenges to and strategies for improving data quality. J Altern Complement Med. 2009;15(12):1319–25.CrossRefPubMed Willson S, Stussman B, Maitland A, Nahin RL. Role of self-concept in answering survey questions on complementary and alternative medicine: challenges to and strategies for improving data quality. J Altern Complement Med. 2009;15(12):1319–25.CrossRefPubMed
12.
Zurück zum Zitat Adams PF KW, Martinez ME. Summary health statistics for the U.S. population: National Health Interview Survey, 2012. National Center for Health Statistics. Vital Health Stat 10(259). 2013. Adams PF KW, Martinez ME. Summary health statistics for the U.S. population: National Health Interview Survey, 2012. National Center for Health Statistics. Vital Health Stat 10(259). 2013.
13.
Zurück zum Zitat Lumley T. Analysis of complex survey samples. J Stat Softw. 2004;9(1):1–19. Lumley T. Analysis of complex survey samples. J Stat Softw. 2004;9(1):1–19.
14.
Zurück zum Zitat Therneau TM, Lumley TR. Survival analysis: [computer program]. CRAN (2014). Therneau TM, Lumley TR. Survival analysis: [computer program]. CRAN (2014).
16.
Zurück zum Zitat Davis MA, Martin BI, Coulter ID, Weeks WB. US spending on complementary and alternative medicine during 2002–08 plateaued, suggesting role in reformed health system. Health Aff (Millwood). 2013;32(1):45–52. doi:10.1377/hlthaff.2011.0321.CrossRef Davis MA, Martin BI, Coulter ID, Weeks WB. US spending on complementary and alternative medicine during 2002–08 plateaued, suggesting role in reformed health system. Health Aff (Millwood). 2013;32(1):45–52. doi:10.​1377/​hlthaff.​2011.​0321.CrossRef
17.
Zurück zum Zitat Greenlee H, Kwan ML, Ergas IJ, Strizich G, Roh JM, Wilson AT, et al. Changes in vitamin and mineral supplement use after breast cancer diagnosis in the pathways study: a prospective cohort study. BMC Cancer. 2014;14(1):382.CrossRefPubMedPubMedCentral Greenlee H, Kwan ML, Ergas IJ, Strizich G, Roh JM, Wilson AT, et al. Changes in vitamin and mineral supplement use after breast cancer diagnosis in the pathways study: a prospective cohort study. BMC Cancer. 2014;14(1):382.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Link AR, Gammon MD, Jacobson JS, Abrahamson P, Bradshaw PT, Terry MB, et al. Use of self-care and practitioner-based forms of complementary and alternative medicine before and after a diagnosis of breast cancer. Evid Based Complement Altern Med. 2013;2013:16. doi:10.1155/2013/301549.CrossRef Link AR, Gammon MD, Jacobson JS, Abrahamson P, Bradshaw PT, Terry MB, et al. Use of self-care and practitioner-based forms of complementary and alternative medicine before and after a diagnosis of breast cancer. Evid Based Complement Altern Med. 2013;2013:16. doi:10.​1155/​2013/​301549.CrossRef
20.
Zurück zum Zitat Miller MF, Bellizzi KM, Sufian M, Ambs AH, Goldstein MS, Ballard-Barbash R. Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study. J Am Diet Assoc. 2008;108(3):483–94. doi:10.1016/j.jada.2007.12.005.CrossRefPubMed Miller MF, Bellizzi KM, Sufian M, Ambs AH, Goldstein MS, Ballard-Barbash R. Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study. J Am Diet Assoc. 2008;108(3):483–94. doi:10.​1016/​j.​jada.​2007.​12.​005.CrossRefPubMed
23.
Zurück zum Zitat Sohl SJ, Weaver KE, Birdee G, Kent EE, Danhauer SC, Hamilton AS. Characteristics associated with the use of complementary health approaches among long-term cancer survivors. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2014;22(4):927–36. Sohl SJ, Weaver KE, Birdee G, Kent EE, Danhauer SC, Hamilton AS. Characteristics associated with the use of complementary health approaches among long-term cancer survivors. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2014;22(4):927–36.
24.
Zurück zum Zitat National Center for Complementary and Alternative Medicine. Complementary, alternative, or integrative health: what’s in a name? National Center for Complementary and Alternative Medicine, Bethesda, Maryland. (2013) http://nccam.nih.gov/health/whatiscam. Accessed 6 Dec 2015. National Center for Complementary and Alternative Medicine. Complementary, alternative, or integrative health: what’s in a name? National Center for Complementary and Alternative Medicine, Bethesda, Maryland. (2013) http://​nccam.​nih.​gov/​health/​whatiscam. Accessed 6 Dec 2015.
25.
Zurück zum Zitat Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep. 2008;10(12):1–23. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep. 2008;10(12):1–23.
26.
Zurück zum Zitat Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol. 2009;7(3):85–120.PubMed Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol. 2009;7(3):85–120.PubMed
27.
Zurück zum Zitat Deng GE, Rausch SM, Jones LW, Gulati A, Kumar NB, Greenlee H, et al. Complementary therapies and integrative medicine in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e420S–36S. doi:10.1378/chest.12-2364.CrossRefPubMed Deng GE, Rausch SM, Jones LW, Gulati A, Kumar NB, Greenlee H, et al. Complementary therapies and integrative medicine in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e420S–36S. doi:10.​1378/​chest.​12-2364.CrossRefPubMed
29.
Zurück zum Zitat Luc L, Baumgart C, Weiss E, Georger L, Ambrosone CB, Zirpoli G, et al. Dietary supplement use among participants of a databank and biorepository at a comprehensive cancer centre. Public Health Nutr. 2015;18(5):916–26. doi:10.1017/s1368980014001062.CrossRefPubMed Luc L, Baumgart C, Weiss E, Georger L, Ambrosone CB, Zirpoli G, et al. Dietary supplement use among participants of a databank and biorepository at a comprehensive cancer centre. Public Health Nutr. 2015;18(5):916–26. doi:10.​1017/​s136898001400106​2.CrossRefPubMed
30.
Zurück zum Zitat Lafferty WE, Tyree PT, Devlin SM, Andersen MR, Diehr PK. Complementary and alternative medicine provider use and expenditures by cancer treatment phase. Am J Manag Care. 2008;14(5):326–34.PubMedPubMedCentral Lafferty WE, Tyree PT, Devlin SM, Andersen MR, Diehr PK. Complementary and alternative medicine provider use and expenditures by cancer treatment phase. Am J Manag Care. 2008;14(5):326–34.PubMedPubMedCentral
36.
Zurück zum Zitat Briggs A, Gray A. The distribution of health care costs and their statistical analysis for economic evaluation. J Health Serv Res Policy. 1998;3(4):233–45.PubMed Briggs A, Gray A. The distribution of health care costs and their statistical analysis for economic evaluation. J Health Serv Res Policy. 1998;3(4):233–45.PubMed
Metadaten
Titel
Complementary and alternative medicine use among US cancer survivors
verfasst von
Gabriella M. John
Dawn L. Hershman
Laura Falci
Zaixing Shi
Wei-Yann Tsai
Heather Greenlee
Publikationsdatum
26.02.2016
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 5/2016
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-016-0530-y

Weitere Artikel der Ausgabe 5/2016

Journal of Cancer Survivorship 5/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.